Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2020
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patientsZhengbo Song, Tianchi Liu, Lei Shi, et al.
Genes, Chromosomes & Cancer|April 9, 2022
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective studyWenxian Wang, Xiaodong Gu, Jinfei Si, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2026
PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell CarcinomaDijian Shen, Rui Li, Yong She, et al.
Frontiers in Oncology|November 9, 2020
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung CancerWenxian Wang, Zhangzhou Huang, Zongyang Yu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2022
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective studyWenxian Wang, Gen Lin, Yue Hao, et al.
The Lancet. Respiratory Medicine|July 7, 2026
Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trialZhengbo Song, Xingya Li, Rongbo Lin, et al.
Clinical Chemistry|December 8, 2019
Simultaneous Detection of Gene Fusions and Base Mutations in Cancer Tissue Biopsies by Sequencing Dual Nucleic Acid Templates in Unified ReactionZhengbo Song, Chunwei Xu, Yunwei He, et al.
Cell Death & Disease|January 22, 2021
Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasisZhengbo Song, Ling Yang, Zhipeng Zhou, et al.
BMC Medicine|September 13, 2021
Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective studyYongchang Zhang, Xiangyu Zhang, Ruiguang Zhang, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2021
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective studyWenxian Wang, Xiaodong Gu, Liping Wang, et al.
Pageof 20